EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Prothrombin complex concentrate administration timing in warfarin-associated intracranial hemorrhage

Brock Townsend, Joe Slechta, Brian W Gilbert

The American Journal of Emergency Medicine · 2024

DOI: 10.1016/j.ajem.2023.11.040 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The American Journal of Emergency Medicine, 2024. Verfasst von Brock Townsend und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy department, Wesley Medical Center, 550 N Hillside St, Wichita, KS 67214, United States of America. Electronic address: brocktownsend01@gmail…. Hauptthemen laut MEDLINE: Anticoagulants, Blood Coagulation Factors, Warfarin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Guidelines recommend "rapid" and "urgent" reversal of anticoagulation for warfarin-associated intracranial hemorrhage (ICH) treatment; however, they do not specify goals for time-to-administration. There are limited studies evaluating time to reversal, or international normalized ratio (INR) correction, on hematoma expansion and outcomes in intervals of 90 min. The primary outcome was rates of achieving effective hemostasis in each group defined as a ≤20% increase in hematoma volume as estimated by a radiologist. RESULTS: A total of 227 patients were screened for inclusion with ultimately 39 being included. Baseline characteristics were similar between groups. The primary outcome was not significantly different among groups stratified by time to 4F-PCC administration of 90 min (85.7% vs 73.3% vs 90%, p value 0.514). There was no difference among secondary outcomes between groups including in-hospital mortality, hospital length of stay (LOS), and intensive care unit LOS. CONCLUSION: There was no association with time-to-administration of 4F-PCC on rates of hemostasis achievement, defined as hematoma expansion of ≤20%, identified in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsBlood Coagulation FactorsWarfarinHumansHematomaInternational Normalized RatioIntracranial HemorrhagesRetrospective Studies

Stichwörter der Autor:innen

Anticoagulation reversalHematoma expansionIntracranial hemorrhageProthrombin complex concentrateWarfarin

Substanzen

AnticoagulantsBlood Coagulation Factorsprothrombin complex concentratesWarfarin

Autor:innen und Institutionen

  • Pharmacy department, Wesley Medical Center, 550 N Hillside St, Wichita, KS 67214, United States of America. Electronic address: brocktownsend01@gmail.com.
  • Pharmacy department, Wesley Medical Center, 550 N Hillside St, Wichita, KS 67214, United States of America.

Zitieren

APA

Townsend, B., Slechta, J., & Gilbert, B. W. (2024). Prothrombin complex concentrate administration timing in warfarin-associated intracranial hemorrhage. The American Journal of Emergency Medicine. https://doi.org/10.1016/j.ajem.2023.11.040

Vancouver

Townsend B, Slechta J, Gilbert BW. Prothrombin complex concentrate administration timing in warfarin-associated intracranial hemorrhage. The American Journal of Emergency Medicine. 2024. doi:10.1016/j.ajem.2023.11.040

BibTeX
@article{Townsend2024,
  author = {Townsend, Brock and Slechta, Joe and Gilbert, Brian W},
  title = {Prothrombin complex concentrate administration timing in warfarin-associated intracranial hemorrhage},
  journal = {The American Journal of Emergency Medicine},
  year = {2024},
  doi = {10.1016/j.ajem.2023.11.040}
}
Kostenlos starten →